跳至主要内容
临床试验/NCT05633628
NCT05633628招募中不适用

Periodic Continuous Glucose Monitoring to Support a Person-centered Approach During Diabetes Consultations in Patients With Type 2 Diabetes- A Randomised Controlled Study

Sophiahemmet University1 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2023年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
400
试验地点
1
主要终点
HbA1c

研究概览

简要总结

The aim of this randomised controlled trial is to investigate the effectiveness of periodic CGM (continuous glucose monitoring) to support a person-centered approach versus self-monitoring of blood glucose (SMBG) in adults with type 2 diabetes on glucose control and patient reported outcomes.

详细描述

This is a 16-week prospective, multicenter, randomised, open-labelled, two-armed study in adults with type 2 diabetes conducted at primary care practices in Sweden.

Periodic CGM group- Intervention group:

The participants in the intervention group will be provided with FreeStyle Libre (Abbott Diabetes Care). Participants wear the sensor and check their glucose level for a period of 28 days (14 days X 2) during week 0-4 and week 10-13.Patient's measurement data from the FreeStyle Libre system 2 will be transferred to the OneTwo Analytics (DDA) analysis tool for an automated analysis and this Insight report will be presented to the participants at visit week 4 (digital) and at visit week 16 (clinical). The diabetes nurse and the patient reviews and discuss trends, patterns, and challenges to support the person's self-care management of their type 2 diabetes. This approach is intended to facilitate communication and patient participation and create the conditions for shared informed decisions and health planning.

Self-monitoring of blood glucose, SMBG and usual care - Control Group The participants in the control group perform SMBG testing as usual including fasting, pre- or post-prandial measurements. They also receive usual care which comprises consultation with physician diabetes specialist or diabetes nurse depending on individual health care needs.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults aged 18-80 years
  • Type 2 diabetes with a duration of > 6 months
  • HbA1c 45-70 mmol/mol
  • Have a smartphone
  • Experience of self-monitoring of blood glucose prior to the study start

排除标准

  • Prandial insulin
  • Pregnancy or planning pregnancy during the study
  • Breastfeeding
  • Renal disease with estimated glomerular filtration rate (eGFR) <45 mL/ min/1.73 m2
  • Active malignancy or under investigation for malignancy
  • Severe visual impairment
  • Severe skin allergy that inhibits the use of a continuous glucose monitoring device
  • Glucocorticoids (systemic)
  • Planned or currently using weight reduction medications, programs, or surgery
  • Cognitively or psychologically unable to participate and read instructions
  • Enrolled in other clinical trials
  • Eating disorders

结局指标

主要结局

HbA1c

时间窗: change at week 16

mmol/mol

次要结局

  • Percentage of time spent in range (Glucose)(change first 28 days in the study compared with the last 28 days)
  • Percentage time spent in hyperglycaemia(change first 28 days in the study compared with the last 28 days)
  • Percentage time spent in hypoglycaemia(change first 28 days in the study compared with the last 28 days)
  • Average glucose value(change first 28 days in the study compared with the last 28 days)
  • Standard deviation for glucose value(change first 28 days in the study compared with the last 28 days)
  • Percentage time in euglycemia, time in target(change first 28 days in the study compared with the last 28 days)
  • Number of hyperglycemic episodes per day(change first 28 days in the study compared with the last 28 days)
  • Number of hypoglycemic episodes per day(change first 28 days in the study compared with the last 28 days)
  • Fasting glucose level(change first 28 days in the study compared with the last 28 days)
  • Data availability in % of all time(change first 28 days in the study compared with the last 28 days)
  • Prandial delta within 2 hours, post - pre-prandial values for breakfast, lunch and dinner.(change first 28 days in the study compared with the last 28 days)
  • Postprandial peak during 2 hours for breakfast, lunch and dinner.(change first 28 days in the study compared with the last 28 days)
  • Night-time insulin effect(change first 28 days in the study compared with the last 28 days)
  • The Diabetes Treatment Satisfaction questionnaire(change at week 16)
  • WHO-5 Well-Being Index(change at week 16)
  • The Patient Preferences for Patient Participation (4Ps)(change at week 16)

研究者

发起方
Sophiahemmet University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Unn-Britt Johansson

Principal Investigator, Professor

Sophiahemmet University

研究点 (1)

Loading locations...

相似试验